Unravelling high-affinity binding compounds towards transmembrane protease serine 2 enzyme in treating SARS-CoV-2 infection using molecular modelling and docking studies.
Saved in:
| Title: | Unravelling high-affinity binding compounds towards transmembrane protease serine 2 enzyme in treating SARS-CoV-2 infection using molecular modelling and docking studies. |
|---|---|
| Authors: | M P; Institute of Pharmaceutical Technology, Sri Padmavati Mahila Visvavidyalayam (Women's University), Tirupati, 517502, Andhra Pradesh, India. Electronic address: poojareddy@spmvv.ac.in., Reddy GJ; Department of Pharmacology, SVU College of Pharmaceutical Sciences, Sri Venkateswara University, Tirupati, 517502, Andhra Pradesh, India., Hema K; Translational Bioinformatics Group, International Centre for Genetic Engineering and Biotechnology, New Delhi, 110067, India., Dodoala S; Institute of Pharmaceutical Technology, Sri Padmavati Mahila Visvavidyalayam (Women's University), Tirupati, 517502, Andhra Pradesh, India., Koganti B; Institute of Pharmaceutical Technology, Sri Padmavati Mahila Visvavidyalayam (Women's University), Tirupati, 517502, Andhra Pradesh, India. |
| Source: | European journal of pharmacology [Eur J Pharmacol] 2021 Jan 05; Vol. 890, pp. 173688. Date of Electronic Publication: 2020 Oct 29. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 1254354 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0712 (Electronic) Linking ISSN: 00142999 NLM ISO Abbreviation: Eur J Pharmacol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
